Position in NVO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$64,150,065
+$4,086,225 QoQ
Shares Held
1,745,580
+47.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,429,349 | $460,653,157 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,216,892 | $406,422,135 | |
| 3 | LLY |
ELI LILLY & Co
|
176,517 | $211,719,802 | |
| 4 | NVS |
Novartis AG
|
1,037,332 | $162,570,671 | |
| 5 | MRK |
Merck & Co., Inc.
|
628,000 | $80,698,000 | |
| 6 | JNJ |
Johnson & Johnson
|
18,956 | $4,814,255 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $1,035,575 | |
| 8 | ABBV |
AbbVie Inc.
|
3,855 | $970,072 |
All Filings in NVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,150,065 | 1,745,580 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $60,063,840 | 1,180,500 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $25,745,150 | 373,010 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $3,518,969 | 24,653 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $61,759,236 | 596,996 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $3,404,322 | 21,392 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||